Cardiolink Science

Cardiolink Science was founded at the end of 2015 as a platform company focused on the research, development, production, sales, and service of vascular interventional medical devices. Headquartered in Shenzhen, the company owns two distinctive technology platforms and GMP-certified Class 10,000 production facilities in both Shenzhen and Beijing. Its product portfolio spans three major areas: oncology intervention, vascular access, and cardiovascular intervention. The founding team, composed of clinical doctors and elite medical device developers, is driven by "Therapy Insight," bridging engineering language with clinical needs to develop and manufacture vascular interventional medical devices tailored for the Chinese population, aiming to alleviate pain and extend life for more patients. Cardiolink Science has two wholly-owned subsidiaries in Beijing: Cardiolink Science (Beijing) Medical Technology Development Co., Ltd. and Heartlink Wisdom (Beijing) Supply Chain Management Development Co., Ltd. The company has successfully completed Series A and B rounds of financing from well-known domestic investment firms.